Clinical Trial Update: Effect of HIV/STD Risk Reduction Program on South African Adolescents [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluates an HIV/STD risk reduction program for South African adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sexually Transmitted Infection

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV Infections, Sexually Transmitted Disease | Phase 2, Phase 3 | Status: COMPLETED